Paper36912451
Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer's disease mouse models.
Sai K and 6 others. J Cell Sci, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer's disease mouse models. Papers, record 36912451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36912451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Animals | |
| Mice | |
| Calcium | |
| Cytokines | |
| Neuroinflammatory Diseases | |
| Signal Transduction | |
| MAP Kinase Kinase Kinase 7 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 ES025128 | NIEHS NIH HHS | United States | P30ES025128 | PubMed and NIH | NIH RePORTER |
| R01 GM112986 | NIGMS NIH HHS | United States | R01GM112986 | PubMed and NIH | NIH RePORTER |
| R35 GM139601 | NIGMS NIH HHS | United States | R35GM139601 | PubMed and NIH | NIH RePORTER |
| R01GM112986 | NIH HHS | United States | R01GM112986 | PubMed and NIH | NIH RePORTER |
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30975711 | Necroptosis mediators RIPK3 and MLKL suppress intracellular Listeria replication independently of host cell killing. | J Cell Biol | 2019 | https://conductscience.org/library/papers/30975711 | PubMed |
| 2 | 24508385 | Necroptosis drives motor neuron death in models of both sporadic and familial ALS. | Neuron | 2014 | https://conductscience.org/library/papers/24508385 | PubMed |
| 3 | 28820959 | Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease. | Cell Chem Biol | 2017 | https://conductscience.org/library/papers/28820959 | PubMed |
| 4 | 25146924 | TAK1 control of cell death. | Cell Death Differ | 2014 | https://conductscience.org/library/papers/25146924 | PubMed |
| 5 | 26985063 | TAK1 determines susceptibility to endoplasmic reticulum stress and leptin resistance in the hypothalamus. | J Cell Sci | 2016 | https://conductscience.org/library/papers/26985063 | PubMed |
| 6 | 2155222 | KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2155222 | PubMed |
| 7 | 12624112 | A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12624112 | PubMed |
| 8 | 20234358 | Microglia in neurodegenerative disease. | Nat Rev Neurol | 2010 | https://conductscience.org/library/papers/20234358 | PubMed |
| 9 | 16876668 | Alzheimer's disease. | Lancet | 2006 | https://conductscience.org/library/papers/16876668 | PubMed |
| 10 | 34161265 | TAK1 inhibition elicits mitochondrial ROS to block intracellular bacterial colonization. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34161265 | PubMed |
| 11 | 17270732 | Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. | Neuron | 2007 | https://conductscience.org/library/papers/17270732 | PubMed |
| 12 | 24703947 | Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. | Mol Cell | 2014 | https://conductscience.org/library/papers/24703947 | PubMed |
| 13 | 25286385 | Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy. | Neuroscience | 2015 | https://conductscience.org/library/papers/25286385 | PubMed |
| 14 | 10882101 | TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. | Mol Cell | 2000 | https://conductscience.org/library/papers/10882101 | PubMed |
| 15 | 16260493 | TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. | Genes Dev | 2005 | https://conductscience.org/library/papers/16260493 | PubMed |
| 16 | 22331902 | Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22331902 | PubMed |
| 17 | 20561356 | Inflammation in neurodegenerative diseases. | Immunology | 2010 | https://conductscience.org/library/papers/20561356 | PubMed |
| 18 | 8292356 | Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. | Neuron | 1994 | https://conductscience.org/library/papers/8292356 | PubMed |
| 19 | 22802624 | Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22802624 | PubMed |
| 20 | 19955178 | Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway. | J Biol Chem | 2010 | https://conductscience.org/library/papers/19955178 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42859261 | Integrative Transcriptomic and Interactome Analyses Prioritize Candidate Genes for Alzheimer's Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42859261 | PubMed |
| 40990233 | Effects of triptolide herb on the progression of Alzheimer's disease preclinical models: a systematic review. | Neurodegener Dis Manag | 2026 | https://conductscience.org/library/papers/40990233 | PubMed |
| 39514156 | Are S100B and VILIP-1 Involved in a Common Mechanism of Neuroinflammation in Major Depressive Disorder? | Psychiatr Q | 2025 | https://conductscience.org/library/papers/39514156 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36912451
GET https://conductscience.org/api/papers/v1/36912451/references?page=2